Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 225,029 | 240,371 | 209,486 | 195,577 | 238,492 |
| Cost of Goods | 143,222 | 120,114 | 103,742 | 105,547 | 124,935 |
| Gross Profit | 81,807 | 120,257 | 105,744 | 90,030 | 113,557 |
| Operating Expenses | 103,204 | 79,946 | 47,704 | 78,862 | 88,485 |
| Operating Income | -21,175 | 40,425 | 58,782 | 11,715 | 26,007 |
| Interest Expense | 6,222 | 3,051 | 3,826 | 3,735 | 4,047 |
| Pre-tax Income | -27,397 | 37,374 | 54,956 | 7,980 | 21,960 |
| Income Tax | -16,356 | 5,492 | 6,855 | -2,547 | 4,336 |
| Net Income Continuous | -11,041 | 31,882 | 48,101 | 10,527 | 17,624 |
| Net Income | $-11,041 | $31,882 | $48,101 | $10,527 | $17,624 |
| EPS Basic Total Ops | -0.22 | 0.63 | 0.95 | 0.21 | 0.35 |
| EPS Basic Continuous Ops | -0.22 | 0.63 | 0.95 | 0.21 | 0.35 |
| EPS Diluted Total Ops | -0.22 | 0.62 | 0.94 | 0.21 | 0.35 |
| EPS Diluted Continuous Ops | -0.22 | 0.62 | 0.94 | 0.21 | 0.34 |
| EBITDA(a) | $874 | $61,338 | $79,800 | $32,586 | $55,368 |